Molecular Medicine (Mar 2018)

MicroRNA-296: a promising target in the pathogenesis of atherosclerosis?

  • Heng Li,
  • Xin-Ping Ouyang,
  • Ting Jiang,
  • Xi-Long Zheng,
  • Ping-Ping He,
  • Guo-Jun Zhao

DOI
https://doi.org/10.1186/s10020-018-0012-y
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Atherosclerosis has been recognized as an inflammatory disease involving the vascular wall. MicroRNAs are a group of small noncoding RNAs to regulate gene expression at the transcriptional level through mRNA degradation or translation repression. Recent studies suggest that miR-296 may play crucial roles in the regulation of angiogenesis, inflammatory response, cholesterol metabolism, hypertension, cellular proliferation and apoptosis. In this review, we primarily discussed the molecular targets of miR-296 involved in the development of atherosclerosis, which may provide a basis for future investigation and a better understanding of the biological functions of miR-296 in atherosclerosis.

Keywords